Nonavalent human papillomavirus vaccination as alternative treatment for genital warts.

Bossart, Simon; Gabutti, Max Philip; Seyed Jafari, Seyed Morteza; Hunger, Robert E. (2020). Nonavalent human papillomavirus vaccination as alternative treatment for genital warts. Dermatologic therapy, 33(4), e13771. Wiley-Blackwell 10.1111/dth.13771

[img] Text
dth.13771.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (672kB) | Request a copy

Genital warts caused by the human papillomavirus (HPV) are the most common sexually transmitted disease and have a negative impact on quality of life. Of the more than 200 different types of HPV, low-risk types 6 and 11 are mainly responsible for the development of condyloma acuminata. Despite a large arsenal of local therapies such as numerous topical agents, CO2 laser ablation, and surgical removal, genital warts tend to be recalcitrant. HPV vaccination is mainly used as a preventive strategy to prevent genital warts, cervical cancer, and other anogenital cancers. However, in a few cases, HPV vaccination has been shown to be a good treatment alternative for patients with recalcitrant skin warts. Here we report five cases of recalcitrant genital warts that responded well to treatment with the nonavalent HPV vaccine. HPV vaccines could be beneficial as a noninvasive treatment alternative for recalcitrant genital warts.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Dermatology

UniBE Contributor:

Bossart, Simon; Gabutti, Max Philip; Jafari, Morteza and Hunger, Robert

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1396-0296

Publisher:

Wiley-Blackwell

Language:

English

Submitter:

Sandra Nyffenegger

Date Deposited:

10 Dec 2020 14:52

Last Modified:

13 Dec 2020 02:51

Publisher DOI:

10.1111/dth.13771

PubMed ID:

32500585

Uncontrolled Keywords:

HPV condyloma acuminatum condylomata acuminata genital warts human papillomavirus vaccination nonavalent

BORIS DOI:

10.7892/boris.148363

URI:

https://boris.unibe.ch/id/eprint/148363

Actions (login required)

Edit item Edit item
Provide Feedback